Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Equity Ratio: 2010-2024

Historic Equity Ratio for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Dec 2024 value amounting to -0.86.

  • Ironwood Pharmaceuticals' Equity Ratio rose 16.55% to -0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.67, marking a year-over-year increase of 16.55%. This contributed to the annual value of -0.86 for FY2024, which is 16.81% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Equity Ratio of -0.86 as of FY2024, which was down 16.81% from -0.74 recorded in FY2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Equity Ratio peaked at 0.59 during FY2022, and registered a low of -0.86 during FY2024.
  • Moreover, its 3-year median value for Equity Ratio was -0.74 (2023), whereas its average is -0.33.
  • In the last 5 years, Ironwood Pharmaceuticals' Equity Ratio soared by 380.02% in 2021 and then plummeted by 224.01% in 2023.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Equity Ratio stood at 0.11 in 2020, then skyrocketed by 380.02% to 0.54 in 2021, then rose by 10.25% to 0.59 in 2022, then tumbled by 224.01% to -0.74 in 2023, then dropped by 16.81% to -0.86 in 2024.